Lupin (LUPIN) — Financial Results

Lupin Limited released unaudited financial results for Q2 and H1 FY2026 ended September 30, 2025. The filing is a regulatory disclosure announcement published in newspapers per SEBI listing requirements. Specific financial metrics including revenue and net profit figures are not detailed in the provided document excerpt, which primarily contains the formal filing notification and unrelated newspaper articles.

📄 View Original Announcement (PDF)

📊 Stock Analysis — LUPIN ✨ Ask AI About This

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

💡 Ask AI about this filing

"How does this financial results affect Lupin Limited's outlook?" "What did Lupin Limited announce on 8 November 2025?" "Is this positive or negative for LUPIN?"

Ask AI Free →

📊 More LUPIN filings

See all LUPIN filings →

🔥 Also filed on 8 November 2025

TITAN Titan Company Limited Financial Results APOLLOHOSP Apollo Hospitals Enterprise Limited Corporate Action DIVISLAB Divi's Laboratories Limited Financial Results HINDALCO Hindalco Industries Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.